Patient characteristics | All patients n = 110 | No pneumonitis patients n = 91 | Pneumonitis patients n = 19 | p-value No pneumonitis vs pneumonitis (≥ grade 1) | |
Age | Â | Â | Â | 0.44 | |
  Median (range) | 68 (34–84) | 67 (34–84) | 69 (53–81) |  | |
Sex | Â | Â | Â | 0.14 | |
  Male | 82 | 65 | 17 |  | |
  Female | 28 | 26 | 2 |  | |
Smoking history | Â | Â | Â | 0.10 | |
  Current | 25 | 19 | 6 |  | |
  Former | 45 | 35 | 10 |  | |
  Never | 40 | 37 | 3 |  | |
Amount of smoking (pack-years) | Â | Â | Â | 0.024 | |
  Median (range) | 21.75 (0–190) | 15.00 (0–98) | 36.75 (0–190) |  | |
Types of cancer | Â | Â | Â | 0.40 | |
  Head and neck cancer | 23 | 17 | 6 |  | |
  Gastric cancer | 17 | 14 | 3 |  | |
  Renal cell cancer | 29 | 23 | 6 |  | |
  Urothelial cancer | 15 | 12 | 3 |  | |
  Malignant melanoma | 25 | 24 | 1 |  | |
  Peritoneal mesothelioma | 1 | 1 | 0 |  | |
BMI (kg/m2) | Â | Â | Â | 0.67 | |
  Median (range) | 20.37 (14.61–36.49) | 20.56 (14.63–36.49) | 20.08 (14.61–32.36) |  | |
Immunotherapy | Â | Â | Â | 0.41 | |
  NIVO | 95 | 79 | 16 |  | |
  PEM | 15 | 12 | 3 |  | |
ILD | Â | Â | Â | 0.068 | |
  Yes | 10 | 6 | 4 |  | |
  No | 100 | 85 | 15 |  | |
Lung metastasis | Â | Â | Â | 0.31 | |
  Yes | 69 | 55 | 14 |  | |
  No | 41 | 36 | 5 |  | |
Treatment line | Â | Â | Â | 0.66 | |
  Median (range) | 2 (1–7) | 2 (1–7) | 3 (1–5) |  | |
TKI | Â | Â | Â | 1.00 | |
  Yes | 28 | 23 | 5 |  | |
  No | 82 | 68 | 14 |  | |
CRP (mg/dl) | Â | Â | Â | 0.82 | |
  Median (range) | 0.98 (0.01–11.97) | 0.98 (0.01–11.97) | 0.79 (0.08–10.49) |  | |
NLR | Â | Â | Â | 0.33 | |
  Median (range) | 3.84 (0.77–39.78) | 3.79 (1.00–39.78) | 4.46 (0.77–11.36) |  | |
Patient characteristics | Asymptomatic (Grade 1) pneumonitis patients n = 7 | Symptomatic (≥ grade 2) pneumonitis patients n = 12 | p-value Asymtomatic (≤ grade 1) vs Symptomatic (≥ grade 2) | ||
Age | Â | Â | 0.72 | ||
  Median (range) | 73 (58–81) | 68.5 (53–74) |  | ||
Sex | Â | Â | 0.28 | ||
  Male | 6 | 11 |  | ||
  Female | 1 | 1 |  | ||
Smoking history | Â | Â | 0.31 | ||
  Current | 2 | 4 |  | ||
  Former | 4 | 6 |  | ||
  Never | 1 | 2 |  | ||
Amount of smoking (pack-years) | Â | Â | 0.057 | ||
  Median (range) | 36.00 (0–67.5) | 40.88 (0–190) |  | ||
Types of cancer | Â | Â | 0.090 | ||
  Head and neck cancer | 4 | 1 |  | ||
  Gastric cancer | 2 | 2 |  | ||
  Renal cell cancer | 0 | 6 |  | ||
  Urothelial cancer | 0 | 3 |  | ||
  Malignant melanoma | 1 | 0 |  | ||
  Peritoneal mesothelioma | 0 | 0 |  | ||
BMI (kg/m2) | Â | Â | 0.69 | ||
  Median (range) | 20.16 (17.63–25.68) | 20.04 (14.61–32.36) |  | ||
Immunotherapy | Â | Â | 0.21 | ||
  NIVO | 7 | 9 |  | ||
  PEM | 0 | 3 |  | ||
ILD | Â | Â | 0.077 | ||
  Yes | 1 | 3 |  | ||
  No | 6 | 9 |  | ||
Lung metastasis | Â | Â | 0.029 | ||
  Yes | 3 | 11 |  | ||
  No | 4 | 1 |  | ||
Treatment line | Â | Â | 0.073 | ||
  Median (range) | 2 (1–3) | 2 (3–5) |  | ||
TKI | Â | Â | 0.18 | ||
  Yes | 0 | 5 |  | ||
  No | 7 | 7 |  | ||
CRP (mg/dl) | Â | Â | 0.71 | ||
  Median (range) | 0.47 (0.25–10.49) | 1.16 (0.08–9.7) |  | ||
NLR | Â | Â | 0.35 | ||
  Median (range) | 3.69 (0.77–11.36) | 4.80 (2.35–10.42) |  |